GlaxoSmithKline Bribery Scandal: Sexual Favors to Increase Sales?

China continues to step up its probe into alleged bribery by British drugmaker GlaxoSmithKline to illegally boost sales and inflate the price of its medicines.
July 18, 2013
Sign up for Pharma Manufacturing Newsletters
Get the latest news and updates